Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

ACR Appropriateness Criteria® mesenteric ischemia.

BIBLIOGRAPHIC SOURCE(S)

  • Gemery JM, Funaki BS, Ray CE Jr, Brown DB, Kinney TB, Kostelic JK, Lorenz JM, Milward SF, Nemcek AA Jr, Owens CA, Reinhart RD, Silberzweig JE, Siskin GP, Vatakencherry G, Moneta GL, Expert Panel on Interventional Radiology. ACR Appropriateness Criteria® mesenteric ischemia. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 4 p. [11 references]

GUIDELINE STATUS

This is the current release of the guideline.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Mesenteric Ischemia

Variant 1: Elderly patient with recent onset abdominal pain, no peritoneal signs, known atrial fibrillation. CT scan shows filling defect in proximal superior mesenteric artery (SMA) consistent with thrombus.

Treatment/Procedure Rating Comments
Anticoagulation 9  
Surgery 8  
Angiography and transcatheter lytic therapy 4 Contraindicated for bowel infarction.
Supportive measures only 2  
Rating Scale: 1=Least appropriate, 9=Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Elderly patient with history of abdominal pain after meals for the past few months and weight loss. CT scan of the abdomen shows aortic atherosclerotic disease and suggests SMA origin stenosis with possible severe stenosis versus occlusion of celiac origin, plus an occluded inferior mesenteric artery (IMA).

Treatment/Procedure Rating Comments
Angiography with possible angioplasty and stent placement 8 Less durable but better risk profile. Failure does not preclude surgery.
Surgery with bypass or endarterectomy 7 Appropriate in select patients. No longer the standard of care.
Anticoagulation 3  
Supportive measures only 2 Some patients may be poor candidates for revascularization procedures.
Rating Scale: 1=Least appropriate, 9=Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Middle-aged patient (40-60 years of age) with pain after meals and CT scan showing widely patent origins of SMA and IMA, with possible compression of the celiac origin by the median arcuate ligament.

Treatment/Procedure Rating Comments
Mesenteric angiography in lateral projection during both inspiration and expiration 8 Gold standard, but would try CTA or MRA first and reserve angiography for select patients.
Surgery with median arcuate ligament release, with or without bypass 8 Has been reported to improve symptoms, but other possible causes of abdominal pain should be ruled out first.
Supportive measures only 5 Controversial entity. Need to rule out other possible causes of abdominal pain.
Anticoagulation 1  
Angioplasty and stent placement 1  
Rating Scale: 1=Least appropriate, 9=Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 4: Hospitalized patient with cardiac disease causing low cardiac output, on lasix. Now with abdominal pain but without peritoneal signs. CT scan shows patent origins and proximal portions of celiac, SMA, and IMA, with some thickening of small bowel walls.

Treatment/Procedure Rating Comments
Angiography with infusion of vasodilator 8 Early initiation of vasodilator therapy is best.
Anticoagulation 5 Theoretically useful, but no data.
Supportive measures only 3 Appropriate when used in conjunction with other therapy.
Surgery 2 Appropriate for resection of infarcted bowel.
Rating Scale: 1=Least appropriate, 9=Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Summary of Literature Review

Diagnosis of Mesenteric Occlusive Disease

Detection of proximal mesenteric arterial occlusive disease is possible with computed tomography (CT), magnetic resonance angiography (MRA), and ultrasound (US). Ostial lesions are reliably evaluated with all three modalities. Both US and MRA have been directly compared with angiography. Multidetector CT scanners, particularly with sagittal reformatting, are capable of demonstrating the proximal mesenteric vessels very well. CT relies on administration of iodinated contrast but does not entail the risks of angiography.

In a patient with renal insufficiency or a history of severe reaction to iodinated contrast, US of the mesenteric vessels origins is preferred over CT. Results will vary considerably with operator expertise, patient body habitus, and presence of bowel gas, but accuracy in detecting ostial abnormality has been reported to be greater than 90%. The more peripheral mesenteric vessels are not as well demonstrated with US or CT scanning, and angiography has remained the best method to evaluate these vessels. Therefore, if clinical suspicion of mesenteric ischemia is high, a negative CT or US exam should not preclude selective mesenteric angiography, particularly if distal disease is a consideration.

Acute Nonocclusive Mesenteric Ischemia

In a patient with signs and symptoms of acute mesenteric ischemia, narrowing of peripheral mesenteric vessels or a pattern of alternating dilatation and narrowing suggests nonocclusive mesenteric ischemia. This diagnosis is best made with conventional angiography, which would also enable initiation of catheter-directed vasodilator infusion therapy. Angiography can provide diagnostic information not available from CT or US. Vasoconstriction may lead to bowel ischemia and necrosis with a mortality rate that has been reported to be 50%. Because early diagnosis and treatment are critically important in acute mesenteric ischemia to avoid bowel infarction, if an angiogram can be obtained rapidly it may be preferable to any delay associated with obtaining noninvasive imaging.

Acute Occlusive Mesenteric Ischemia

Thrombolysis for treatment of mesenteric thrombosis or embolus has been reported. While it is technically feasible and in many reported cases successful, a recent review article identified published reports of thrombolytic therapy covering only a total of 43 patients. Thrombolysis could be applied in only a minority of patients presenting with acute mesenteric ischemia. Thrombolysis is contraindicated in bowel infarction, and any indication of bowel infarction (peritoneal symptoms, pneumoperitoneum, or intramural air on CT) is an indication for urgent surgery rather than thrombolysis. The inability to confidently exclude bowel infarction in many patients with mesenteric ischemia has limited widespread use of thrombolysis. Due to the presence of vasospasm associated with occlusive mesenteric ischemia, catheter-directed vasodilator infusion may also be of benefit in some patients with occlusive mesenteric ischemia, especially prior to more definitive therapy.

Chronic Mesenteric Ischemia

Chronic mesenteric ischemia most commonly occurs due to atherosclerotic occlusive disease of the mesenteric arteries (celiac axis, superior mesenteric artery, inferior mesenteric artery). Signs and symptoms of chronic mesenteric ischemia include weight loss, sitophobia (food fear), and abdominal pain after eating. Given the relatively rich collateral supply to bowel, signs and symptoms of ischemia typically occur when at least two arteries (and often all three) are affected. Endovascular therapy, particularly angioplasty and stenting, has supplanted open surgical repair as the preferred therapy for mesenteric origin stenoses in patients without bowel infarction. Mortality and morbidity are believed to be lower for endovascular interventions compared to open repair.

Median Arcuate Ligament Syndrome

The median arcuate ligament is a fibrous band connecting the right and left hemidiaphragms and is found in up to 20% of the population. The incidence, and even existence, of abdominal symptoms due to compression of the celiac artery by the median arcuate ligament is debatable. The compression has been postulated to limit blood flow to bowel with resulting ischemic symptoms or to irritate the celiac ganglion, which results in abdominal pain. Compression of the celiac artery may be a normal finding in asymptomatic patients and is well characterized.

Patients with imaging evidence of celiac axis compression have been treated with best results in patients who had both celiac decompression (surgical division of the ligament) and some form of celiac artery revascularization. Predictors for successful outcome were "postprandial pain pattern (81% cured), age between 40 and 60 (77% cured), and weight loss of 20 pounds or more (67% cured)". There is no current evidence that supports use of angioplasty and stenting in this entity, and endovascular dilation may be contraindicated unless ligament release has been performed first.

Summary

  • Noninvasive tests such as CTA, MRA, or US should be the initial diagnostic imaging tests of choice for evaluating chronic mesenteric ischemia. These modalities can reliably diagnose proximal occlusive disease. Conventional angiography is reserved for diagnosis of distal disease or performed concurrently with endovascular treatment.
  • Angioplasty and stent insertion have shown promising results in treating chronic mesenteric ischemia due to proximal mesenteric occlusive disease and are considerably less invasive than open surgical bypass.
  • Because rapid diagnosis and treatment are mandatory in acute mesenteric ischemia, if clinical suspicion is high, conventional angiography is the best overall modality for diagnosis, particularly if it can be obtained with minimal delay.
  • Thrombolysis for acute occlusive mesenteric ischemia is predicated on an ability to confidently exclude bowel infarction.
  • Patients with acute nonocclusive mesenteric ischemia may benefit from catheter-directed intra-arterial vasodilator infusion. Some patients with acute occlusive mesenteric ischemia may also benefit from vasodilator infusion prior to more definitive therapy.

Abbreviations

  • CT, computed tomography
  • CTA, computed tomography angiography
  • IMA, inferior mesenteric artery
  • MRA, magnetic resonance angiography
  • SMA, superior mesenteric artery

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Gemery JM, Funaki BS, Ray CE Jr, Brown DB, Kinney TB, Kostelic JK, Lorenz JM, Milward SF, Nemcek AA Jr, Owens CA, Reinhart RD, Silberzweig JE, Siskin GP, Vatakencherry G, Moneta GL, Expert Panel on Interventional Radiology. ACR Appropriateness Criteria® mesenteric ischemia. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 4 p. [11 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2008

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Interventional Radiology

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: John M. Gemery, MD; Brian S. Funaki, MD; Charles E. Ray, Jr, MD; Daniel B. Brown, MD; Thomas B. Kinney, MD; Jon K. Kostelic, MD; Jonathan M. Lorenz, MD; Steven F. Millward, MD; Albert A. Nemcek Jr, MD; Charles A. Owens, MD; Robert D. Reinhart, MD; James E. Silberzweig, MD; Gary P. Siskin, MD; George Vatakencherry, MD; Gregory L. Moneta, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on June 24, 2009.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo